Current Hypertension Reports

, Volume 15, Issue 3, pp 232–237 | Cite as

Role of Ambulatory Blood Pressure Monitoring in Resistant Hypertension

  • Guido Grassi
  • Michele Bombelli
  • Gino Seravalle
  • Gianmaria Brambilla
  • Raffaella Dell’Oro
  • Giuseppe Mancia
Therapeutic Trials (G Mancia, Section Editor)

Abstract

Ambulatory blood pressure monitoring has gained growing popularity in the diagnosis and treatment of essential hypertension for several reasons, such as the lack of the so-called white-coat effect, the greater reproducibility as compared with clinic blood pressure, the ability to provide information on blood pressure phenomena of prognostic value and the closer relationship with the risk of cardiovascular morbidity and mortality. All the above-mentioned main features of ambulatory blood pressure monitoring are also true for resistant hypertension. In addition, however, in resistant hypertension, blood pressure monitoring allows one to precisely define the diagnosis of this clinical condition, by excluding the presence of white-coat hypertension, which is responsible for a consistent number of “false” resistant hypertensive cases. The approach also allows one to define the patterns of blood pressure variability in this clinical condition, as well as its relationships with target organ damage. Finally, it allows one to assess the effects of therapeutic interventions, such as renal nerves ablation, aimed at improving blood pressure control in this hypertensive state. The present paper will critically review the main features of ambulatory blood pressure monitoring in resistant hypertension, with particular emphasis on the diagnosis and treatment of this high-risk hypertensive state.

Keywords

Ambulatory blood pressure monitoring ABPM Blood pressure variability Renal denervation White coat hypertension Organ damage Resistant hypertension 

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. 1.
    Muxfeldt ES, Bloch KV, Nogueira AR, Salles GF. Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension. Blood Press Monit. 2003;8:181–5.PubMedCrossRefGoogle Scholar
  2. 2.
    Mancia G, De Backer G, Dominiczak A, The Task force for the management of arterial hypertension of the European Society of Hypertension, The task force for the management of arterial hypertension of the European Society of Cardiology, et al. Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and of European Society of Cardiology. J Hypertens. 2007;25:1105–87.PubMedCrossRefGoogle Scholar
  3. 3.
    Shafi S, Sarac E, Tran H. Ambulatory blood pressure monitoring in patients with chronic kidney disease and resistant hypertension. J Clin Hypertens. 2012;14:611–7.CrossRefGoogle Scholar
  4. 4.
    Nasothimiou EG, Tzamouranis D, Roussias LG, Stergiou GS. Home versus ambulatory blood pressure monitoring in the diagnosis of clinic resistant and true resistant hypertension. J Hum Hypertens. 2012;26:696–700.PubMedCrossRefGoogle Scholar
  5. 5.
    •• Rothwell PM. Does blood pressure variability modulate cardiovascular risk? Curr Hypertens Rep. 2011;13:177–86. The review highlights the clinical and prognostic value of day-by-day blood pressure variability in hypertension.PubMedCrossRefGoogle Scholar
  6. 6.
    Grassi G, Bombelli M, Brambilla G, et al. Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications. Curr Hypertens Rep. 2012;14:333–8.PubMedCrossRefGoogle Scholar
  7. 7.
    •• Mancia G, Bombelli M, Seravalle G, Grassi G. Diagnosis and management of white-coat and masked hypertension. Nat Rev Cardiol. 2011;8:686–93. A comprehensive review article discussing the pathophysiological and clinical profile of these two common clinical conditions.PubMedCrossRefGoogle Scholar
  8. 8.
    •• Calhoun DA, Jones D, Textor S, American Heart Association Professional Education Committee, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117:e510–26. The document examines in a comprehensive fashion the main diagnostic and therapeutic features of resistant hypertension.PubMedCrossRefGoogle Scholar
  9. 9.
    Grassi G, Seravalle G, Brambilla G, et al. Novel antihypertensive therapies: renal sympathetic nerve ablation and carotid baroreceptor stimulation. Curr Hypertens Rep. 2012;14:567–72.PubMedCrossRefGoogle Scholar
  10. 10.
    Syrseloudis D, Andrikou I, Andrikou E, et al. Ambulatory blood pressure monitoring in resistant hypertension. Int J Hypertens. 2011;2011:285612.PubMedGoogle Scholar
  11. 11.
    •• Doumas M, Anyfanti P, Bakris G. Should ambulatory blood pressure monitoring be mandatory for future studies in resistant hypertension: a perspective. J Hypertens. 2012;30:874–6. The paper critically discusses the role of ambulatory blood pressure monitoring in resistant hypertension.PubMedCrossRefGoogle Scholar
  12. 12.
    Muxfeldt ES, Bloch KV, Nogueira Ada R, Salles GF. True resistant hypertension: is it possible to be recognized in the office? Am J Hypertens. 2005;18:1534–40.PubMedCrossRefGoogle Scholar
  13. 13.
    Redon J, Campos C, Narciso ML, et al. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension. 1998;31:712–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Veglio F, Rabbia F, Riva P, et al. Ambulatory blood pressure monitoring and clinical characteristics of the true and white-coat resistant hypertension. Clin Exp Hypertens. 2001;23:203–11.PubMedCrossRefGoogle Scholar
  15. 15.
    Gorostidi M, Sobrino J, Segura J, Spanish Society of Hypertension ABPM Registry Investigators, et al. Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20,000-patient database in Spain. J Hypertens. 2007;25:977–84.PubMedCrossRefGoogle Scholar
  16. 16.
    Salles GF, Cardoso CR, Muxfeldt ES. Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Intern Med. 2008;168:2340–6.PubMedCrossRefGoogle Scholar
  17. 17.
    •• De la Sierra A, Segura J, Banegas JR, et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension. 2011;57:898–902. The Spanish registry is one of the largest studies providing information on resistant hypertension in current clinical practice.PubMedCrossRefGoogle Scholar
  18. 18.
    Mancia G, Sega R, Bravi C, et al. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens. 1995;13:1377–90.PubMedCrossRefGoogle Scholar
  19. 19.
    Bombelli M, Facchetti R, Brambilla G, et al. Clinic, home, 24-hour blood pressure profiles and clinical correlates in resistant hypertension: data from the PAMELA study. J Hypertens. 2012;30:e53 [Abstract].Google Scholar
  20. 20.
    Grassi G, Cifkova R, Laurent S, et al. Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study. Eur Heart J. 2011;32:218–25.PubMedCrossRefGoogle Scholar
  21. 21.
    Brambilla G, Bombelli M, Seravalle G, et al. Prevalence and clinical characteristics of patients with true resistant hypertension in central and eastern europe: data from the BP-CARE study. J Hypertens. 2013, submitted.Google Scholar
  22. 22.
    Seravalle G, Volpe M, Ganz F, et al. Neuroadrenergic profile in patients with resistant hypertension. J Hypertens. 2011;29:e141 [Abstract].CrossRefGoogle Scholar
  23. 23.
    Mancia G. Short-term and long-term blood pressure variability. In: Berbari AE, Mancia G, editors. Special issues in hypertension. Milan: Springer; 2012. p. 91–102.CrossRefGoogle Scholar
  24. 24.
    Poulsen PL, Ebbehøj E, Hansen KW, Mogensen CE. 24-h blood pressure and autonomic function is related to albumin excretion within the normoalbuminuric range in IDDM patients. Diabetologia. 1997;40:718–25.PubMedCrossRefGoogle Scholar
  25. 25.
    Verdecchia P, Schillaci G, Guerrieri M, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation. 1990;81:528–36.PubMedCrossRefGoogle Scholar
  26. 26.
    Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 1989;79:733–43.PubMedCrossRefGoogle Scholar
  27. 27.
    Verdecchia P, Schillaci G, Borgioni C, et al. Altered circadian blood pressure profile and prognosis. Blood Press Monit. 1997;2:347–52.PubMedGoogle Scholar
  28. 28.
    Sega R, Corrao G, Bombelli M, et al. Blood pressure variability and organ damage in a general population: results from the PAMELA study (Pressioni Arteriose Monitorate E Loro Associazioni). Hypertension. 2002;39:710–4.PubMedCrossRefGoogle Scholar
  29. 29.
    Mancia G, Bombelli M, Facchetti R, et al. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni study. Hypertension. 2007;49:1265–70.PubMedCrossRefGoogle Scholar
  30. 30.
    Kikuya M, Ohkubo T, Metoki H, et al. Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama study. Hypertension. 2008;52:1045–50.PubMedCrossRefGoogle Scholar
  31. 31.
    Hansen TW, Thijs L, Li Y, Boggia J, International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators, et al. Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension. 2010;55:1049–57.PubMedCrossRefGoogle Scholar
  32. 32.
    •• Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895–905. One of the first systematic reports on the prognostic value of day-by-day blood pressure variability.PubMedCrossRefGoogle Scholar
  33. 33.
    Rothwell PM. Limitations of the usual blood-pressure: hypothesis and importance of variability, instability, and episodic hypertension. Lancet. 2010;375:938–48.PubMedCrossRefGoogle Scholar
  34. 34.
    •• Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275–81. First uncontrolled study assessing the blood pressure lowering effects of renal denervation in resistant hypertension.PubMedCrossRefGoogle Scholar
  35. 35.
    •• Symplicity HTN-2 Investigators, Esler MD, Krum H, Sobotka PA, et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903–9. The study reports the results of a new randomized controlled trial on the effects of renal denervation on clinic blood pressure in resistant hypertension.PubMedCrossRefGoogle Scholar
  36. 36.
    Volpe M, Facchetti R, Magni L, et al. Blood pressure variability in resistant hypertension: data from the PAMELA study. High Blood Press Cardiovasc Prev. 2012;19:145 [Abstract].Google Scholar
  37. 37.
    Zuern CS, Rizas KD, Eick C, et al. Effects of renal sympathetic denervation on 24-hour blood pressure variability. Front Physiol. 2012;3:134.PubMedCrossRefGoogle Scholar
  38. 38.
    Gosse P, Coulon P. Ambulatory or home measurement of blood pressure? J Clin Hypertens. 2009;11:234–7.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Guido Grassi
    • 1
    • 2
  • Michele Bombelli
    • 1
  • Gino Seravalle
    • 1
  • Gianmaria Brambilla
    • 1
  • Raffaella Dell’Oro
    • 1
  • Giuseppe Mancia
    • 1
  1. 1.Clinica Medica, Dipartimento di Medicina Clinica, Prevenzione e Biotecnologie SanitarieUniversità Milano-Bicocca, Ospedale San GerardoMonzaItaly
  2. 2.IRCCS MultimedicaSesto San GiovanniItaly

Personalised recommendations